Critical Care Transport of Patients With COVID-19
Overview
Authors
Affiliations
Purpose: Critical care transport is associated with a high rate of adverse events, and the risks and outcomes of transporting critically ill patients during the COVID-19 pandemic have not been previously described.
Materials And Methods: We performed a retrospective review of transports of subjects with suspected or confirmed COVID-19 from sending hospitals to tertiary care hospitals in Boston. Follow-up data were obtained for patients transported between March 1st and April 20th, 2020.
Results: Of 254 charts identified, 250 patients were transported. Nine patients (3.5%) had cardiac arrest prior to transport. Twenty-nine (11.6%) had hypotension, 22 (8.8%) had a critical desaturation, and 4 (1.6%) had both en route. Hospital follow-up data were available for 189 patients. Of those intubated during their hospitalization, 44 (25.0%) had died, 59 (33.5%) had been extubated, and 13 (17.6%) had been discharged alive. For the subgroup with prior cardiac arrest, follow-up data available for 6. Of these 6, 2 died and 4 (66.7%) have been discharged alive.
Conclusions: Few patients with COVID-19 had an adverse event in transport. The in-hospital mortality rate was 25%, with a 33.5% extubation rate. Patients resuscitated from cardiac arrest prior to transport had a 66.7% discharge rate among those transported to consortium hospitals.
Stark A, Chohan S J Intensive Care Soc. 2023; 24(3):277-282.
PMID: 37744069 PMC: 9548487. DOI: 10.1177/17511437221111638.
Shang Y, Wu J, Liu J, Long Y, Xie J, Zhang D J Intensive Med. 2023; 2(4):199-222.
PMID: 36785648 PMC: 9411033. DOI: 10.1016/j.jointm.2022.07.001.
Guo Y, Li Y, Wang Y, Liang P, He X, Yu B Front Public Health. 2023; 10:926872.
PMID: 36684915 PMC: 9845581. DOI: 10.3389/fpubh.2022.926872.
Slagt C, Spoelder E, Tacken M, Frijlink M, Servaas S, Leijte G Respir Res. 2022; 23(1):256.
PMID: 36123727 PMC: 9484339. DOI: 10.1186/s12931-022-02177-5.
Ioannides K, Dekker A, Shin M, Schriger D Ann Emerg Med. 2022; 80(4):301-313.e3.
PMID: 35940995 PMC: 9356618. DOI: 10.1016/j.annemergmed.2022.05.036.